What is the 13F Pro Quality Score for ACHV?

13F Pro ranks ACHIEVE LIFE SCIENCES, INC. (ACHV) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ACHV's current score at https://13fpro.ai/research/ACHV (free sign-up required for the full ranking).

Where does 13F Pro source ACHV data?

All ACHIEVE LIFE SCIENCES, INC. fundamentals and ownership data come directly from SEC EDGAR. ACHIEVE LIFE SCIENCES, INC. files with the SEC under CIK 949858. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ACHV in?

ACHIEVE LIFE SCIENCES, INC. (ACHV) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ACHV research updated on 13F Pro?

ACHV's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

ACHIEVE LIFE SCIENCES, INC.(ACHV)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 949858 ACHV stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Below size threshold

Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

ACHV Stock Analysis & AI Quality Score

AI stock analysis and institutional research for ACHIEVE LIFE SCIENCES, INC. (ACHV), a Healthcare sector company. ACHV is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Based on the latest XBRL financial filings (Q1 2026), ACHIEVE LIFE SCIENCES, INC. reports net income of $-10.2M, free cash flow of $-6.9M. Top institutional holders of ACHV by reported 13-F value include FRANKLIN RESOURCES, Propel Bio Management,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ACHV trades on the Nasdaq exchange and files with the SEC under CIK 949858. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACHV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for ACHIEVE LIFE SCIENCES, INC. directly from SEC EDGAR.

Net Income

Q1 2026

$-10.2M

Free Cash Flow

Q1 2026

$-6.9M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

—FY 2024

FY21 —FY22 —FY23 —FY24 —

Net Income

-33.6% YoY

$-39.8MFY 2024

FY21 $-33.2MFY22 $-42.4MFY23 $-29.8MFY24 $-39.8M

EPS (Diluted)

+17.3% YoY

$-1.24FY 2024

FY21 $-4.08FY22 $-4.00FY23 $-1.50FY24 $-1.24

Total Assets

+99.4% YoY

$38.6MFY 2024

FY21 $47.5MFY22 $30.0MFY23 $19.4MFY24 $38.6M

Op. Cash Flow

-21.6% YoY

$-29.8MFY 2024

FY21 $-29.4MFY22 $-37.6MFY23 $-24.5MFY24 $-29.8M

Metric	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Revenue	—	—	—	—	—	$0.00
Net Income	$-39.8M -33.6%	$-29.8M +29.6%	$-42.4M -27.7%	$-33.2M -125.1%	$-14.7M +10.2%	$-16.4M
EPS (Diluted)	$-1.24 +17.3%	$-1.50 +62.5%	$-4.00 +2.0%	$-4.08 +24.7%	$-5.42	—
Total Assets	$38.6M +99.4%	$19.4M -35.4%	$30.0M -36.9%	$47.5M +17.9%	$40.3M +91.2%	$21.1M
Operating Cash Flow	$-29.8M -21.6%	$-24.5M +34.8%	$-37.6M -27.6%	$-29.4M -118.5%	$-13.5M +11.4%	$-15.2M

AI Insight: ACHV Financial Trends

Cash burn accelerated through Q4 2025, then improved in Q1 2026, but equity has collapsed 74% from Q2 2024 to present.

• Operating cash flow deteriorated from −$5M in Q2 2024 to −$18M in Q4 2025, then improved to −$7M in Q1 2026.

• Net losses sustained at $10–15M per quarter; Q1 2026 showed marginal improvement to −$10M from −$15M in Q4 2025.

• Shareholder equity fell from $42M (Q2 2024) to $11M (Q1 2026), signaling rapid capital depletion.

⚠ Q1 2026 cash burn deceleration may signal operational adjustments, but trajectory unsustainable at current rate.

⚠ Equity at $11M leaves minimal runway; refinancing or revenue inflection critical within 2–3 quarters.

AI Insight: ACHV Ratio Trends

Insufficient data to assess trends — only two quarters report returns metrics, both deeply negative.

• ROE deteriorated from -80.0% in Q2 2024 to -171.8% in Q3 2025, indicating persistent unprofitability and shareholder value destruction.

• ROA worsened from -52.2% in Q2 2024 to -86.3% in Q2 2025, showing declining asset productivity.

⚠ Operating margin, NPM, ROIC, and D/E ratios absent across all periods — limits ability to assess profitability, leverage, or operational efficiency trends.

Get alerted when ACHV's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for ACHIEVE LIFE SCIENCES, INC. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ACHV

FRANKLIN RESOURCES INC
$12.8M4,369,193 sh
Propel Bio Management, LLC
$11.4M3,786,425 sh
VANGUARD CAPITAL MANAGEMENT LLC
$6.5M2,204,714 sh
Simplify Asset Management Inc.
$3.5M1,184,512 sh
MILLENNIUM MANAGEMENT LLC
$3.2M1,077,338 sh
MARSHALL WACE, LLP
$3.0M1,019,281 sh
LPL Financial LLC
$2.1M728,448 sh
Nantahala Capital Management, LLC
$1.9M648,885 sh
RAYMOND JAMES FINANCIAL INC
$1.9M641,925 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.8M622,785 sh

Fund	Value	Shares
FRANKLIN RESOURCES INC	$12.8M	4,369,193
Propel Bio Management, LLC	$11.4M	3,786,425
VANGUARD CAPITAL MANAGEMENT LLC	$6.5M	2,204,714
Simplify Asset Management Inc.	$3.5M	1,184,512
MILLENNIUM MANAGEMENT LLC	$3.2M	1,077,338
MARSHALL WACE, LLP	$3.0M	1,019,281
LPL Financial LLC	$2.1M	728,448
Nantahala Capital Management, LLC	$1.9M	648,885
RAYMOND JAMES FINANCIAL INC	$1.9M	641,925
GEODE CAPITAL MANAGEMENT, LLC	$1.8M	622,785

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ACHV on your watchlist

Track score changes the day ACHIEVE LIFE SCIENCES, INC. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ACHV a good stock to buy?

13F Pro's AI-powered analysis of ACHIEVE LIFE SCIENCES, INC. (ACHV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ACHV are available on the ACHV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own ACHV?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ACHV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of ACHIEVE LIFE SCIENCES, INC.'s investment landscape.